Brian has long said that health care needs a start, not a finish. With the passage of the 2009 Patient Protection and Affordable Care Act, our nation took a critical first step by giving millions of Americans access to health insurance, including those who had never had access before, like individuals with pre-existing conditions, and making sure that the high cost of medical treatments do not force families into bankruptcy. Brian supports efforts in Congress to come together across the aisle and improve the law, bringing down the cost curve and making the quality of care better for all Americans.
More on Health Care
Congressman Brian Higgins (NY-26) recently took to the House of Representatives Floor to raise awareness of the need for a renewed national focus on preventing, treating and caring for those with Alzheimer’s disease.
Today, thousands of advocates from across the country gather in Washington, D.C. to rally in support of medical research funding. The crowd in the nation’s capital will include more than 50 researchers from Roswell Park Cancer Institute.
Congressman Brian Higgins (NY-26) announced that researchers at University at Buffalo have been awarded a grant for $333,805 by the National Institute on Drug Abuse to study treatments for chronic pain that will prevent the risk of abuse or development of tolerance.
Congressman Brian Higgins (NY-26) joined Roswell Park Cancer Institute (RPCI) President & CEO Dr. Donald Trump and American Cancer Society Cancer Action Network (ACS CAN) Federal Government Relations Director Hillary Clarke to outline the local impact of federal investments in cancer research and the devastating impact cuts, including possible sequestration, would have on both the economy and the effort to improve cancer outcomes.
Congressman Brian Higgins (NY-26) applauded the work of local families fighting to address the prescription drug epidemic. Late last week three Western New Yorkers testified at a hearing of the U.S. Food and Drug Administration’s (FDA) Drug Safety and Risk Management Advisory Committee. After hearing their stories and other compelling evidence, the panel voted 19-10 to call for stricter controls on the prescription of highly addictive hydrocodone medications.
In advance of hearings on strengthening hydrocodone regulation, Congressman Brian Higgins wrote a letter to the Food and Drug Administration (FDA) asking that the personal experiences of those testifying, including that of Western New Yorker, Avi Israel, be taken into serious consideration as policy considerations are made.